All News
ACR Comments on JAK Inhibitors and FDA Announcement
Following is a statement from ACR President David Karp, MD, PhD, on JAK inhibitors and FDA drug safety communication.
Read ArticleRheumNow Podcast – High Science and Future Treatments (9.10.2021)
This week: high science that affect future treatments; breakthrough infections in our patients, and what's up with that; and soon your radiologist is going to be replaced by AI. This and more in our review of the news and journal articles from the past week.
Read ArticleFDA Review of Vaping Products Extended
The FDA has again extended its decision on whether the manufacturers of vaping products can market their e-cigarettes in the United States.
Read ArticleRisk Factors Associated with Systemic Sclerosis Hospitalization
A retrospective study of systemic sclerosis patients shows that acute hospitalization and mortality were not uncommon and were often linked to SSc-related lung disease.
Read Article
Links:

Links:

Links:
Dr. John Cush RheumNow ( View Tweet)

Links:
Dr. John Cush RheumNow ( View Tweet)

Links:
Dr. John Cush RheumNow ( View Tweet)

Links:
Dr. John Cush RheumNow ( View Tweet)

Links:

Links:

Links:
Dr. John Cush RheumNow ( View Tweet)


Rheumatology Advisor RheumAdvisor ( View Tweet)

Lupus Association LADAOrg ( View Tweet)

Links:

Links:
Dr. John Cush RheumNow ( View Tweet)

Links:
Dr. John Cush RheumNow ( View Tweet)

Dr. John Cush RheumNow ( View Tweet)